Finance
Lilly’s stock rallies as sales of GLP-1 drugs nearly double
Sales of Mounjaro and Zepbound both beat expectations
M
MarketWatch
April 30, 2026·1 min read
Image: MarketWatch
Sales of Mounjaro and Zepbound both beat expectations
Original article
Lilly’s stock rallies as sales of GLP-1 drugs nearly double
Published by MarketWatch